Chewy Vet Care Growth Adds Flywheel Support but Not Yet a Valuation Driver

What happened

Chewy's Vet Care segment posted triple-digit growth, with management highlighting strong clinic economics, customer satisfaction, and retention as drivers of the health services expansion. This aligns with the company's 'flywheel' strategy pairing Autoship, Chewy Plus, and Vet Care to boost retention and net sales per active customer, which reached $595 in Q3 FY2025. However, the news item provides no revenue contribution or margin details, making it difficult to assess whether vet care is accretive or dilutive to gross margin, which expanded to 29.8% in Q3 FY2025 and is the core lever for adjusted EBITDA expansion. At 51x P/E and 38x EV/EBITDA, the stock already prices in significant operational upside, so incremental validation of a sub-scale segment is unlikely to materially move the needle. We view this as a positive but non-transformational data point that supports the existing thesis without changing our base-case valuation of $30.

Implication

Investors should monitor whether Vet Care can sustain triple-digit growth without eroding consolidated gross margin or requiring excessive capex, as clinic scale-up often carries fixed costs and hiring risks. The news supports the retention flywheel, but at current multiples the stock needs more than niche growth; confirmation of FY2026 adjusted EBITDA margin guidance at or above 6% remains the primary catalyst. If vet care begins contributing materially to customer retention and NSPAC without margin sacrifice, the bull case for $38 gains credibility; otherwise the stock remains a 'show-me' story.

Thesis delta

No material change to the investment thesis. The vet care growth reinforces the customer retention flywheel but lacks disclosed financial impact, and the core thesis still hinges on sustained gross margin expansion and FY2026 guidance, not on services revenue acceleration.